In vitro, γ-guanidinobutyramide (HL523) stimulates in muscle glucose uptake, glycogenosis,
glycolysis and glucose oxidation; in adipose tissue glucose oxidation; and insulin
secretion in pieces of pancreatic tissue incubated at physiological glucose concentration.
These metabolic effects of HL523 can account for its hypoglycemic action in vivo.
γ-Guanidinobutyramide - Glucose Metabolism - Glycogen - Insulin Secretion - Diaphragm
- Adipose Tissue